Literature DB >> 19227649

The nocebo effect during oral challenge in subjects with adverse drug reactions.

C Lombardi1, S Gargioni, G W Canonica, G Passalacqua.   

Abstract

BACKGROUND: Nocebo effect is the occurrence of troublesome symptoms after the administration of inert substances. It can be easily studied during blind oral challenges for drug reactions, which always involve the administration ofa placebo.
METHODS: We collected data about nocebo effect in outpatients undergoing oral drug challenge. Patients with previous documented adverse reactions to drugs underwent an oral challenge with alternative drugs to identify the compounds that can be safely used The challenges involved the administration of aplacebo before the active drugs and were performed under medical supervision.
RESULTS: Four hundred and thirty-five patients (18-68 yrs, 68% female) underwent the oral drug challenge. Most of them (52%) had a previous reaction with antibiotics and non-steroidal antinflammatory drugs. The reported reactions were urticaria (and/or angioedema), respiratory complaints, generalized itching and non-specific symptoms. A nocebo effect was seen in 13patients (3%), (10 female). The majority of the observed effects were subjective (malaise, itching, abdominal pain). No special demographic or clinical characteristic could be identified in the nocebo reactors. Ten/13 patients had an abnormal result at the hospital anxiety depression questionnaire.
CONCLUSION: Nocebo effect was not negligible in this procedure, although lessfrequent than previously reported.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19227649

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  9 in total

1.  Multiple drug intolerance syndrome and multiple drug allergy syndrome: Epidemiology and associations with anxiety and depression.

Authors:  K G Blumenthal; Y Li; W W Acker; Y Chang; A Banerji; S Ghaznavi; C A Camargo; L Zhou
Journal:  Allergy       Date:  2018-10       Impact factor: 13.146

Review 2.  The nocebo effect and its relevance for clinical practice.

Authors:  Luana Colloca; Franklin G Miller
Journal:  Psychosom Med       Date:  2011-08-23       Impact factor: 4.312

3.  Qualitative study of Nocebo Phenomenon (NP) involved in doctor-patient communication.

Authors:  Bushra Ashraf; Muhammad Saaiq; Khaleeq-Uz- Zaman
Journal:  Int J Health Policy Manag       Date:  2014-06-02

Review 4.  Nocebo phenomena in medicine: their relevance in everyday clinical practice.

Authors:  Winfried Häuser; Ernil Hansen; Paul Enck
Journal:  Dtsch Arztebl Int       Date:  2012-06-29       Impact factor: 5.594

5.  [Patients with adverse drug reactions have a higher prevalence of emotional disorders].

Authors:  Elizabeth Gutiérrez-Islas; Brenda Beatriz Báez-Montiel; José Luis Turabián; Margarita Bolaños-Maldonado; Juan Ramón Herrera-Ontañón; Alejandro Villarín Castro; Francisco López de Castro
Journal:  Aten Primaria       Date:  2012-09-11       Impact factor: 1.137

6.  The effects of distraction on symptoms during drug provocation test.

Authors:  Songul Cildag; Taskin Senturk; Gokhan Sargin
Journal:  Clujul Med       Date:  2017-01-15

7.  Outcomes from an inpatient beta-lactam allergy guideline across a large US health system.

Authors:  Kimberly G Blumenthal; Yu Li; Joyce T Hsu; Anna R Wolfson; David N Berkowitz; Victoria A Carballo; Jesse M Schwartz; Kathleen A Marquis; Ramy Elshaboury; Ronak G Gandhi; Barbara B Lambl; Monique M Freeley; Alana Gruszecki; Paige G Wickner; Erica S Shenoy
Journal:  Infect Control Hosp Epidemiol       Date:  2019-03-27       Impact factor: 3.254

8.  [Results of a pilot study on the role of therapy expectation in interdisciplinary multimodal pain therapy for chronic back pain].

Authors:  Dustin Maser; Daniel Müller; Ulrike Bingel; Diana Müßgens
Journal:  Schmerz       Date:  2021-10-07       Impact factor: 1.629

9.  How to prevent, minimize, or extinguish nocebo effects in pain: a narrative review on mechanisms, predictors, and interventions.

Authors:  Meriem Manaï; Henriët van Middendorp; Dieuwke S Veldhuijzen; Tom W J Huizinga; Andrea W M Evers
Journal:  Pain Rep       Date:  2019-06-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.